Adcetris 50 MG vial 1S
Ended Awarded
- Contract number
- SPE2DR26FBTDY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,721
Award facts
- Contract value 100% obligated
- $49,720.56 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,720.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Adcetris (brentuximab vedotin) 50 mg vials. This delivery order was issued without set-aside designation on November 20, 2025, with performance to occur at DMS Pharmaceutical Group's Park Ridge facility. The award represents one of numerous delivery orders issued to the contractor under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Defense Logistics Agency acquisition strategy designed to streamline pharmaceutical supply to Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under PPV-G GEN V (contract SPE2DR) valued at $499,999,999 through December 31, 2036, positioning the company as a regional prime vendor contractor within the broader DoD pharmaceutical supply chain. Adcetris is a specialty oncology biologic used in cancer treatment, consistent with the contractor's established product portfolio that encompasses branded and generic prescription medications, biologics, vaccines, and medical consumables. The company's demonstrated federal contracting activity and performance across multiple therapeutic categories reflects its capability as a critical supplier supporting recurring medical supply needs of the Defense Logistics Agency and military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FBTDY?
SPE2DR26FBTDY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FBTDY worth?
The government has obligated $49,721 on SPE2DR26FBTDY.
Is contract SPE2DR26FBTDY an order under another contract?
Yes. SPE2DR26FBTDY is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTDY competed?
The extent of competition for SPE2DR26FBTDY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award